Table 1.
Clinical and imaging characteristics of included patients (N = 62)
| N = 62 | |
|---|---|
| Age (yrs, mean ± SD) | 65.97(±11.66) |
| Male (n,%) | 35 (56.5) |
| Presence of diabetes mellitus (DM) | 24 (38.7) |
| Charlson age-comorbidity index (CCI, median, range) | 5 (2–9) |
| Preoperative CA19–9 (U/mL, median, range) | 133.1 (2–12,000) |
| Postoperative CA19–9 (U/mL, median, range) | 34.4 (0.39–12,000) |
| Interval between initial imaging and operation date (mo., median, range) | 0.5 (0.5–20) |
| Adjuvant chemotherapy (n,%) | 46 (74.2) |
| Location of tumor | |
| Head/ Body/Tail | 38/12/12 |
| Vascular invasion | 38 (61.3) |
| Celiac trunk/SMA/CHA | 7 (11.3) |
| PV/SMV/portomesenteric confluence | 16 (25.8) |
| Others: IVC, left renal vein | 3 (4.8) |
| Conspicuity score > 2 | 25 (40.3) |
| Radiologic tumor size (cm) | 2.78(±0.87) |
| Resectability | |
| Resectable/borderline resectable/unresectable | 37/23/2 |
| Presence of obstructive pancreatitis (n, %) | 50 (80.6) |
| Presence of double primary cancer (n,%) | 6 (9.6) |
SD standard deviation, SMA superior mesenteric artery, SMV superior mesenteric vein, CHA common hepatic artery, PV portal vein, IVC inferior vena cava